NVAX DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing